VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
about
Treatment of disseminated non-seminomatous testicular cancer: the European experience.High-dose chemotherapy and stem cell transplantation for advanced testicular cancerHigh-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administrationPeripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimen.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.Transplantation for refractory germ cell tumors: does it really make a difference?Non-Seminomatous Germ Cell Tumor Presenting with Superior Vena Cava Syndrome.Recent developments in the management of germ cell tumors.Germ cell tumours in uncorrected cryptorchid testis at Institute Rotary Cancer Hospital, New Delhi.The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursSalvage therapy of germ cell tumours.Hepatic resection for disseminated germ cell carcinoma.Multidisciplinary Clinic Approach Improves Overall Survival Outcomes of Patients with Metastatic Germ Cell Tumors.High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
P2860
Q33788904-6EA1A7A8-449A-4E10-A48E-245C3ADDD2B4Q35660641-FA2C101D-B3FC-4148-82C5-46BA7BD8AC33Q36420168-CD8FF6B4-D60F-48BE-BE01-65936C42CF82Q36962991-368DE8AC-E51E-4C1C-9D94-64C60DF0138FQ37875412-C5F65426-7536-49D2-AA2E-4AFEA9FC7246Q37905875-1FB97685-1909-44EB-8A97-807CD4A18440Q38089677-4CEF372A-FDCE-456C-8635-3A0B219023D6Q38619169-1BACB8B2-48BE-4E26-9D29-A7C4828EF021Q38984439-6C4A7FB0-D74E-487D-B2ED-2AD596E69F1DQ40582297-55739A27-B5E0-488B-8418-76FC2439D3F3Q41812469-3001F636-1A1C-4A12-8F50-6E2E30AE0D20Q41925418-4037D919-32C2-428E-8DF4-6CDDE13000C1Q42280644-18D63723-01D2-42B0-AE49-49EC529A24CAQ42590636-4703E0A8-73F2-4E26-9A61-77FE60D05D32Q45194180-D389C69C-82F4-43C4-B599-4EF00EEAAA6BQ47217042-13C86F29-8F2D-44BA-8122-A1864EAC8A0CQ47626519-F00FBC3D-1070-4E74-B49C-1273E03A9934
P2860
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
@en
type
label
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
@en
prefLabel
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
@en
P2093
P356
P1476
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
@en
P2093
L H Einhorn
P J Loehrer
S D Williams
P304
P356
10.1200/JCO.1986.4.4.528
P407
P577
1986-04-01T00:00:00Z